| 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 固体制剂(元) | 112,937,691.21 | 201,130,576.14 | 90,666,102.54 |
| 原料药(元) | - | 2,884,766.35 | 1,390,504.41 |
| 注射剂(元) | 201,523,377.52 | 518,724,294.20 | 257,948,110.98 |
| 其他主营业务(元) | - | - | 52,004,567.99 |
| 其他(元) | 66,060,857.96 | 117,917,525.30 | 52,004,567.99 |
| 营业成本(元) | |||
| 固体制剂(元) | 15,845,236.74 | 50,380,524.32 | 17,874,239.28 |
| 原料药(元) | - | 4,889,879.13 | 2,319,433.77 |
| 注射剂(元) | 51,837,110.87 | 119,103,601.37 | 55,201,669.70 |
| 其他主营业务(元) | - | - | 11,833,351.82 |
| 其他(元) | - | 25,293,446.03 | 11,833,351.82 |
| 毛利(元) | |||
| 固体制剂(元) | 97,092,454.47 | 150,750,051.82 | 72,791,863.26 |
| 原料药(元) | - | -2,005,112.78 | -928,929.36 |
| 注射剂(元) | 149,686,266.65 | 399,620,692.83 | 202,746,441.28 |
| 其他主营业务(元) | - | - | 40,171,216.17 |
| 其他(元) | - | 92,624,079.27 | 40,171,216.17 |
| 毛利率(%) | |||
| 固体制剂(%) | 85.97 | 74.95 | 80.29 |
| 原料药(%) | - | -69.51 | -66.81 |
| 注射剂(%) | 74.28 | 77.04 | 78.60 |
| 其他主营业务(%) | - | - | 77.25 |
| 其他(%) | - | 78.55 | 77.25 |
| 收入构成(%) | |||
| 固体制剂(%) | 29.68 | 23.93 | 19.97 |
| 原料药(%) | 0.00 | 0.34 | 0.31 |
| 注射剂(%) | 52.96 | 61.70 | 56.82 |
| 其他主营业务(%) | - | - | 11.45 |
| 其他(%) | 17.36 | 14.03 | 11.45 |
| 毛利构成(%) | |||
| 固体制剂(%) | 39.34 | 23.52 | 20.51 |
| 原料药(%) | 0.00 | -0.31 | -0.26 |
| 注射剂(%) | 60.66 | 62.34 | 57.12 |
| 其他主营业务(%) | - | - | 11.32 |
| 其他(%) | 0.00 | 14.45 | 11.32 |